JAK inhibitor treatment using upadacitinib reduces disease severity in palmoplantar pustulosis, warranting further study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results